[DISCLOSURE] Boryung Pharmaceutical (003850) reported on July 21 that it has obtained a patent in South Africa for an antihypertensive pharmaceutical composition, a combination of hydrochlorothiazide and fimasartan.

It applied for the patent to gain approval to supply the medicine overseas, Boryung said.